Similarly, an ALK fusion was noted in the CTCs, matching the patient’s primary tumor (P 17) (Figure 5B), and a 3′ deletion of RET was found in recovered CTCs from a patient with a RET rearranged tumor (P 26) (Figure 5C). This evidence concerns the gene ALK and neoplasm.